Metabolic Alterations Associated to Brain Dysfunction in Diabetes

被引:75
作者
Duarte, Joao M. N. [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging LIFMET, Lausanne, Switzerland
来源
AGING AND DISEASE | 2015年 / 6卷 / 05期
基金
瑞士国家科学基金会;
关键词
Neurodegeneration; Diabetes; Alzheimer's disease; Insulin; Metabolism; HIPPOCAMPAL SYNAPTIC PLASTICITY; ACTIVATED PROTEIN-KINASE; HIGH-ENERGY PHOSPHATES; MAGNETIC-RESONANCE-SPECTROSCOPY; NERVOUS-SYSTEM COMPLICATIONS; INSULIN-DEGRADING ENZYME; BETA-AMYLOID PEPTIDES; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; SEVERE HYPOGLYCEMIA;
D O I
10.14336/AD.2014.1104
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
From epidemiological studies it is known that diabetes patients display increased risk of developing dementia. Moreover, cognitive impairment and Alzheimer's disease (AD) are also accompanied by impaired glucose homeostasis and insulin signalling. Although there is plenty of evidence for a connection between insulin-resistant diabetes and AD, definitive linking mechanisms remain elusive. Cerebrovascular complications of diabetes, alterations in glucose homeostasis and insulin signalling, as well as recurrent hypoglycaemia are the factors that most likely affect brain function and structure. While difficult to study in patients, the mechanisms by which diabetes leads to brain dysfunction have been investigated in experimental models that display phenotypes of the disease. The present article reviews the impact of diabetes and AD on brain structure and function, and discusses recent findings from translational studies in animal models that link insulin resistance to metabolic alterations that underlie brain dysfunction. Such modifications of brain metabolism are likely to occur at early stages of neurodegeneration and impact regional neurochemical profiles and constitute non-invasive biomarkers detectable by magnetic resonance spectroscopy (MRS).
引用
收藏
页码:304 / 321
页数:18
相关论文
共 202 条
[1]   Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats [J].
Abdul-Rahman, Omar ;
Sasvari-Szekely, Maria ;
Ver, Agota ;
Rosta, Klara ;
Szasz, Bernadett K. ;
Kereszturi, Eva ;
Keszler, Gergely .
BMC GENOMICS, 2012, 13
[2]  
Adriaanse SM, 2014, EUR J NUCL IN PRESS
[3]   Role of hypothalamic adenosine 5′-monophosphate activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia [J].
Alquier, Thierry ;
Kawashima, Junji ;
Tsuji, Youki ;
Kahn, Barbara B. .
ENDOCRINOLOGY, 2007, 148 (03) :1367-1375
[5]  
[Anonymous], 2013, DIABETES ATLAS, V6th
[6]   MRI OF THE BRAIN IN DIABETES-MELLITUS [J].
ARAKI, Y ;
NOMURA, M ;
TANAKA, H ;
YAMAMOTO, H ;
YAMAMOTO, T ;
TSUKAGUCHI, I ;
NAKAMURA, H .
NEURORADIOLOGY, 1994, 36 (02) :101-103
[7]   Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats [J].
Ates, Ozkan ;
Cayli, Suleyman R. ;
Yucel, Neslihan ;
Altinoz, Eyup ;
Kocak, Ayhan ;
Durak, M. Akif ;
Turkoz, Yusuf ;
Yologlu, Saim .
JOURNAL OF CLINICAL NEUROSCIENCE, 2007, 14 (03) :256-260
[8]   Effects of repeated hypoglycemia on cognitive function - A psychometrically validated reanalysis of the Diabetes Control and Complications Trial Data [J].
Austin, EJ ;
Deary, IJ .
DIABETES CARE, 1999, 22 (08) :1273-1277
[9]   Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes [J].
Baker, Laura D. ;
Cross, Donna J. ;
Minoshima, Satoshi ;
Belongia, Dana ;
Watson, Stennis ;
Craft, Suzanne .
ARCHIVES OF NEUROLOGY, 2011, 68 (01) :51-57
[10]  
Barber M, 2003, BRAIN RES, V964, P128, DOI [10.1016/S0006-8993(02)04091-X, 10.1016/s0006-8993(02)04091-X]